BACKGROUND: Gradient echo T2*-W sequences are more sensitive than T2-W spin-echo sequences for detecting hemorrhages in the brain. OBJECTIVE: The aim of this study is to correlate presence of hemosiderin deposits in the brain of very preterm infants (gestational age <32 weeks) detected by T2*-W gradient echo MRI to white matter injury and neurodevelopmental outcome at 2 years. MATERIALS AND METHODS: In 101 preterm infants, presence and location of hemosiderin were assessed on T2*-W gradient echo MRI performed around term-equivalent age (range: 40-60 weeks). White matter injury was defined as the presence of >6 non-hemorrhagic punctate white matter lesions (PWML), cysts and/or ventricular dilatation. Six infants with post-hemorrhagic ventricular dilatation detected by US in the neonatal period were excluded. Infants were seen for follow-up at 2 years. Univariate and regression analysis assessed the relation between presence and location of hemosiderin, white matter injury and neurodevelopmental outcome. RESULTS: In 38/95 (40%) of the infants, hemosiderin was detected. Twenty percent (19/95) of the infants were lost to follow-up. There was a correlation between hemosiderin in the ventricular wall with >6 PWML (P < 0.001) and cysts (P < 0.001) at term-equivalent age, and with a lower psychomotor development index (PDI) (P=0.02) at 2 years. After correcting for known confounders (gestational age, gender, intrauterine growth retardation and white matter injury), the correlation with PDI was no longer significant. CONCLUSION: The clinical importance of detecting small hemosiderin deposits is limited as there is no independent association with neurodevelopmental outcome.
BACKGROUND: Gradient echo T2*-W sequences are more sensitive than T2-W spin-echo sequences for detecting hemorrhages in the brain. OBJECTIVE: The aim of this study is to correlate presence of hemosiderin deposits in the brain of very preterm infants (gestational age <32 weeks) detected by T2*-W gradient echo MRI to white matter injury and neurodevelopmental outcome at 2 years. MATERIALS AND METHODS: In 101 preterm infants, presence and location of hemosiderin were assessed on T2*-W gradient echo MRI performed around term-equivalent age (range: 40-60 weeks). White matter injury was defined as the presence of >6 non-hemorrhagic punctate white matter lesions (PWML), cysts and/or ventricular dilatation. Six infants with post-hemorrhagic ventricular dilatation detected by US in the neonatal period were excluded. Infants were seen for follow-up at 2 years. Univariate and regression analysis assessed the relation between presence and location of hemosiderin, white matter injury and neurodevelopmental outcome. RESULTS: In 38/95 (40%) of the infants, hemosiderin was detected. Twenty percent (19/95) of the infants were lost to follow-up. There was a correlation between hemosiderin in the ventricular wall with >6 PWML (P < 0.001) and cysts (P < 0.001) at term-equivalent age, and with a lower psychomotor development index (PDI) (P=0.02) at 2 years. After correcting for known confounders (gestational age, gender, intrauterine growth retardation and white matter injury), the correlation with PDI was no longer significant. CONCLUSION: The clinical importance of detecting small hemosiderin deposits is limited as there is no independent association with neurodevelopmental outcome.
Authors: Lara M Leijser; Francisca T de Bruïne; Sylke J Steggerda; Jeroen van der Grond; Frans J Walther; Gerda van Wezel-Meijler Journal: Early Hum Dev Date: 2009-01-13 Impact factor: 2.079
Authors: Francisca T de Bruïne; Annette A van den Berg-Huysmans; Lara M Leijser; Monique Rijken; Sylke J Steggerda; Jeroen van der Grond; Gerda van Wezel-Meijler Journal: Radiology Date: 2011-10-26 Impact factor: 11.105
Authors: Emily W Y Tam; Glenn Rosenbluth; Elizabeth E Rogers; Donna M Ferriero; David Glidden; Ruth B Goldstein; Hannah C Glass; Robert E Piecuch; A James Barkovich Journal: J Pediatr Date: 2010-09-15 Impact factor: 4.406
Authors: Lianne J Woodward; Caron A C Clark; Verena E Pritchard; Peter J Anderson; Terrie E Inder Journal: Dev Neuropsychol Date: 2011 Impact factor: 2.253
Authors: Catherine Limperopoulos; Haim Bassan; Kimberlee Gauvreau; Richard L Robertson; Nancy R Sullivan; Carol B Benson; Lauren Avery; Jane Stewart; Janet S Soul; Steven A Ringer; Joseph J Volpe; Adré J duPlessis Journal: Pediatrics Date: 2007-09 Impact factor: 7.124
Authors: Gerda van Wezel-Meijler; Lara M Leijser; Francisca T de Bruïne; Sylke J Steggerda; Jeroen van der Grond; Frans J Walther Journal: Early Hum Dev Date: 2009-01-12 Impact factor: 2.079
Authors: Clara Adriana Maria de Bruijn; Stefano Di Michele; Maria Luisa Tataranno; Luca Antonio Ramenghi; Andrea Rossi; Mariya Malova; Manon Benders; Agnes van den Hoogen; Jeroen Dudink Journal: Pediatr Res Date: 2022-09-09 Impact factor: 3.953
Authors: Charlotte van 't Westende; Sylke J Steggerda; Lisette Jansen; Annette A van den Berg-Huysmans; Laura A van de Pol; Francisca T Wiggers-de Bruine; Cornelis J Stam; Cacha M P C D Peeters-Scholte Journal: Pediatr Res Date: 2021-05-24 Impact factor: 3.953
Authors: S J Steggerda; F T de Bruïne; V E H J Smits-Wintjens; P Verbon; F J Walther; G van Wezel-Meijler Journal: Eur Radiol Date: 2015-04-22 Impact factor: 5.315
Authors: Karina J Kersbergen; Manon J N L Benders; Floris Groenendaal; Corine Koopman-Esseboom; Rutger A J Nievelstein; Ingrid C van Haastert; Linda S de Vries Journal: PLoS One Date: 2014-10-03 Impact factor: 3.240